CytoDyn Inc. financial data

Symbol
CYDY on OTC
Location
Vancouver, WA
Fiscal year end
31 May
Latest financial report
10-Q - Q4 2025 - 09 Jan 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 21% % -0.03%
Debt-to-equity -115% % 2.5%
Return On Equity 38% % 174%
Return On Assets -252% % -229%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,270,395,000 shares 3.4%
Common Stock, Shares, Outstanding 1,265,853,000 shares 3.5%
Entity Public Float $134,520,000 USD -14%
Common Stock, Value, Issued $1,266,000 USD 3.4%
Weighted Average Number of Shares Outstanding, Basic 1,261,016,000 shares 3.2%
Weighted Average Number of Shares Outstanding, Diluted 1,261,016,000 shares 3.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $7,240,000 USD 175%
General and Administrative Expense $6,865,000 USD -29%
Costs and Expenses $35,702,000 USD 485%
Operating Income (Loss) $35,702,000 USD -511%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $38,861,000 USD -173%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $38,861,000 USD -173%
Earnings Per Share, Basic -0.04 USD/shares -300%
Earnings Per Share, Diluted -0.04 USD/shares -300%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $4,982,000 USD -77%
Inventory, Net $0 USD
Assets, Current $8,839,000 USD -64%
Operating Lease, Right-of-Use Asset $65,000 USD -67%
Other Assets, Noncurrent $96,000 USD -61%
Assets $8,935,000 USD -64%
Accounts Payable, Current $14,245,000 USD 0.01%
Employee-related Liabilities, Current $266,000 USD 24%
Liabilities, Current $85,112,000 USD 21%
Operating Lease, Liability, Noncurrent $0 USD -100%
Other Liabilities, Noncurrent $43,571,000 USD 0%
Liabilities $128,683,000 USD 13%
Retained Earnings (Accumulated Deficit) $915,933,000 USD -4.4%
Stockholders' Equity Attributable to Parent $119,748,000 USD -34%
Liabilities and Equity $8,935,000 USD -64%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $2,450,000 USD -145%
Net Cash Provided by (Used in) Financing Activities $121,000 USD -101%
Common Stock, Shares Authorized 2,250,000,000 shares 29%
Common Stock, Shares, Issued 1,266,139,000 shares 3.5%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,571,000 USD -117%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4,982,000 USD -77%
Interest Paid, Excluding Capitalized Interest, Operating Activities $13,000 USD -71%
Deferred Tax Assets, Valuation Allowance $126,203,000 USD -1.9%
Deferred Tax Assets, Gross $126,230,000 USD -1.9%
Operating Lease, Liability $69,000 USD -67%
Depreciation $18,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid $77,000 USD -70%
Operating Lease, Liability, Current $69,000 USD -51%
Lessee, Operating Lease, Liability, to be Paid, Year Two $169,000 USD -8.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $169,000 USD -8.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,000 USD -84%
Deferred Tax Assets, Operating Loss Carryforwards $97,626,000 USD -3.2%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $794,919,000 USD 1.1%
Deferred Tax Assets, Net of Valuation Allowance $27,000 USD -51%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%